Impilo Therapeutics Overview
- Year Founded
-
2019
- Status
-
Acquired/Merged
- Employees
-
2
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Impilo Therapeutics General Information
Description
Operator of a drug discovery and development company intended to focus on nucleic acid-based medicines to effectively treat solid tumor cancers. The company's platform provides a tumor-targeted tissue penetration capability to specifically enhance nucleic acid drug delivery to tumors, enabling medical professionals to treat solid tumor cancers.
Contact Information
Website
www.impilotherapeutics.com(Operating Subsidiary)
Corporate Office
- 1286 University Avenue
- Suite 362
- San Diego, CA 92103
- United States
Corporate Office
- 1286 University Avenue
- Suite 362
- San Diego, CA 92103
- United States
Impilo Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Impilo Therapeutics Patents
Impilo Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024097310-A2 | Targeted non-charged-nucleic acid (ncna) delivery and related tumor penetrating nanocomplexes | Inactive | 01-Nov-2022 | ||
| WO-2024097310-A3 | Targeted non-charged-nucleic acid (ncna) delivery and related tumor penetrating nanocomplexes | Inactive | 01-Nov-2022 |
Impilo Therapeutics Signals
Impilo Therapeutics FAQs
-
When was Impilo Therapeutics founded?
Impilo Therapeutics was founded in 2019.
-
Where is Impilo Therapeutics headquartered?
Impilo Therapeutics is headquartered in San Diego, CA.
-
What is the size of Impilo Therapeutics?
Impilo Therapeutics has 2 total employees.
-
What industry is Impilo Therapeutics in?
Impilo Therapeutics’s primary industry is Drug Discovery.
-
Is Impilo Therapeutics a private or public company?
Impilo Therapeutics is a Private company.
-
What is Impilo Therapeutics’s current revenue?
The current revenue for Impilo Therapeutics is .
-
When was Impilo Therapeutics acquired?
Impilo Therapeutics was acquired on 21-Sep-2020.
-
Who acquired Impilo Therapeutics?
Impilo Therapeutics was acquired by Cend Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process